← Leaderboards
Yuet Ming Rebecca Chin
Beth Israel Deaconess Medical Center
$1,049,335
Attributed
$1,049,335
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $245.3K · FY2011–16$250K$187.5K$125K$62.5K$0
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,049,335 · 2
By mechanism
R00$711,079 · 1
K99$338,256 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Kermit L Carraway$11,333,366
- Ramesh K Ganju$10,257,043
- Lewis C Cantley$35,988,650
- Alex Toker$16,651,718
- Martin R. Pollak$37,233,145
Others in their field
Top investigators on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$278,513,775
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
Research focus
InsightInstitutionActinsEnvironmentDimensionsBiochemicalBioinformaticsAnti-Cancer TherapeuticAntineoplastic AgentsBreast Cancer CellBaseAdvisory CommitteesBundlingCancer CellCarcinomaCareerCell GrowthCell MotilityCell NucleusCell ProliferationCell SurvivalCytoplasmDesignIn Vivo
Grant awards (5)
Akt isoform-specific signaling in breast cancer metastasis$241,629
R00 · FY2016 · CA · contact PI
Akt isoform-specific signaling in breast cancer metastasis$245,350
R00 · FY2015 · CA · contact PI
Akt isoform-specific signaling in breast cancer metastasis$224,100
R00 · FY2014 · CA · contact PI
Akt isoform-specific signaling in breast cancer metastasis$169,128
K99 · FY2012 · CA · contact PI
Akt isoform-specific signaling in breast cancer metastasis$169,128
K99 · FY2011 · CA · contact PI